EXECUTION COPY


 


AGREEMENT


 


This Agreement (the “Agreement”), dated as of December 7, 2011, by and between CYTOSORBENTS CORPORATION, a Nevada corporation, (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).


 


WHEREAS:


 


A.           The Company and the Investor are parties to a Purchase Agreement dated as of May 5, 2010 (the “Purchase Agreement”), pursuant to which, among other things, the Company has the right to sell to the Investor, at its sole discretion, up to $6,000,000 of the Company’s common stock, par value $0.001 per share (“Common Stock”), upon the terms and subject to the conditions of the Purchase Agreement;


 


B.           The Company and the Investor are parties to a Registration Rights Agreement dated as of May 5, 2010 (the “Registration Rights Agreement”), pursuant to which, among other things, the Company agreed to file a registration statement with the Securities and Exchange Commission (“SEC”) covering the Purchase Shares and Additional Commitment Shares of  issued and issuable pursuant to the Purchase Agreement; and


 


C.           The Company and the Investor desire to terminate the Purchase Agreement and the Registration Rights Agreement and all of their respective obligations thereunder by mutual agreement in accordance with the terms and subject to the conditions herein set forth;


 


NOW, THEREFORE, in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:


 



	
  

	
1.

	
The Company and Investor hereby mutually agree to terminate the Purchase Agreement and the Registration Rights Agreement, and all of the Company’s and the Investor’s respective future covenants, agreements, obligations and commitments thereunder, effective as of December 7, 2011 and any and all rights, duties and obligations arising thereunder or in connection with the Purchase Agreement, and the Transaction Documents (other than this Agreement) are now and hereafter fully and finally terminated, provided, however, that (i) the representations and warranties of the Investor and Company contained in Sections 3 and 4 of the Purchase Agreement, (ii) the indemnification provisions set forth in Section 9 of the Purchase Agreement, and (iii) the agreements and covenants set forth in Section 12 of the Purchase Agreement shall survive such termination for a period of twelve (12) months succeeding the date of this Agreement in accordance with the Purchase Agreement.  This Agreement, the rights of the parties under and in connection herewith, and all actions arising in whole or part under or in connection herewith will be governed by and construed in accordance with the laws of the State of Illinois. The parties hereby irrevocably and unconditionally submit to the jurisdiction of any federal or state court located sitting in the City of Chicago, County of Cook and State of Illinois over any dispute for purposes of any action, suit or proceeding arising out of or relating to this Agreement. Each party irrevocably waives any objection it may have to the venue of any action, suit or proceeding brought in such court or to the convenience of the forum. No modification or waiver of any provision hereof shall be enforceable unless approved by the Investor in writing. No failure or delay in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement.







 




  





  











  






 



	
  

	
2.

	
Any notices, consents or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt when delivered personally; (ii) upon receipt when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one business day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses and facsimile numbers for such communications shall be:







 


If to the Company:


 


CytoSorbents Corporation


7 Deer Park Drive, Suite K


Monmouth Junction, NJ 08852


Telephone:          732-329-8885


Facsimile:            732-329-8650


Attention:           Chief Executive Officer


 


With a copy to:


 


Anslow & Jaclin LLP


195 Route 9 South


Manalapan NJ 07726


Telephone:          732-409-1212


Facsimile:            732-577-1188


Attention:           Gregg E. Jaclin, Esq.


 


If to the Investor:


 


Lincoln Park Capital Fund, LLC


440 North Wells, Suite 620


 




  





  











  






 


Chicago, IL 60654


Telephone:          312-822-9300


Facsimile:            312-822-9301


Attention:           Josh Scheinfeld/Jonathan Cope


 


If to the Transfer Agent:


 


American Stock Transfer and Trust Company


59 Maiden Lane


Plaza Level


New York, NY 10038


Telephone:  718-921-8257


Facsimile:    718-921-8355


Attention:


 


or at such other address and/or facsimile number and/or to the attention of such other person as the recipient party has specified by written notice given to each other party three (3) business days prior to the effectiveness of such change.  Written confirmation of receipt (A) given by the recipient of such notice, consent or other communication, (B) mechanically or electronically generated by the sender’s facsimile machine containing the time, date, and recipient facsimile number or (C) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) of this Section 6, respectively.


 


[Signature Page Follows]


 




  





  











  











IN WITNESS WHEREOF, the Investor and the Company have caused this Agreement to be duly executed as of the date first written above.


 




	  	
THE COMPANY:


	  	  
	  	
CYTOSORBENTS CORPORATION


	  	  
	  	
By:

	  /s/ Phillip Chan	  
	  	
Name:

	
Phillip Chan

	  
	  	
Title:

	
 Chief Executive Officer

	  
	  	  	  
	  	
INVESTOR:

	  
	  	  	  
	  	
LINCOLN PARK CAPITAL FUND, LLC


	  	
BY: ROCKLEDGE CAPITAL CORPORATION


	  	  	  
	  	
By:

	/s/ Josh Scheinfeld	  
	  	Name: Josh Scheinfeld	  
	  	Title: President